ResMed invests in Scottish tech start-up
By HME News Staff
Updated 9:30 AM CST, Thu December 2, 2021
SAN DIEGO – ResMed has made a minority investment in Lenus Health, an Edinburgh, Scotland-based health-tech startup that specializes in improving outcomes and lowering costs for people with chronic obstructive pulmonary disease, according to the Scottish Business Times. “Lenus Health’s achievements underscore the power of digital health to improve people’s lives, delivering care closer to home while also significantly reducing health care costs for whole systems,” said Antoine Valterio, ResMed UK country manager. “ResMed is looking forward to helping Lenus Health accelerate the adoption of digital health and AI technologies in the NHS and abroad, as part of our ongoing commitment to supporting a thriving UK health tech sector.” Lenus Health’s technology combines wearables and artificial intelligence to remotely monitor a COPD patient’s wellbeing, predict when their condition may worsen, and enable their care teams to intervene earlier, helping prevent exacerbations and hospitalizations.
Comments